title: [Effects of matrine on proliferation and apoptosis of human renal cell carcinoma cell line GRC-1].
abstract: OBJECTIVE
  To observe the effects of matrine on proliferation and apoptosis of human renal cell carcinoma cell line GRC-1 in vitro, and to explore its mechanism.
  
  
  METHODS
  The human renal cell carcinoma cell line GRC-1 was treated with matrine of different concentrations for 24, 48, 72 and 96 h respectively. The MTT assay was used to evaluate the cytotoxic effects of matrine on GRC-1 cells. The transmission electron microscope and flow cytometry were utilized to observe and detect the apoptosis of GRC-1 cells induced by matrine. The expression levels of Bcl-2 and Bax proteins were evaluated by streptavidin-biotin-peroxidase method.
  
  
  RESULTS
  The matrine of different concentrations all have cytotoxic effects on GRC-1 cells, with obvious dose- and time-dependent effects. The apoptosis induced by matrine was confirmed in GRC-1 cells. With intervention of matrine (1.5 g/L) for 12 h, the expression level of Bcl-2 in GRC-1 cells was decreased while the expression level of Bax was increased as compared with those in the untreated group.
  
  
  CONCLUSIONS
  The proliferation-inhibiting effects of matrine on human renal cell carcinoma cell line GRC-1 may be related to down-regulating the ratio of Bcl-2/Bax protein expression and promoting the apoptosis.
authors.affiliation: Department of Urology, Second Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi Province 710004, China. chongtie123@163.com
authors.forename: Tie
authors.initials: T
authors.lastname: Chong
authors.forename: Jian-Qiang
authors.initials: JQ
authors.lastname: Niu
authors.forename: Zi-Ming
authors.initials: ZM
authors.lastname: Wang
authors.forename: Jun-Jun
authors.initials: JJ
authors.lastname: She
authors.forename: Chen
authors.initials: C
authors.lastname: Huang
mesh_terms: D000470:Alkaloids / Q000494:pharmacology*; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D015536:Down-Regulation / Q000187:drug effects; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D019253:Proto-Oncogene Proteins c-bcl-2; D011807:Quinolizines / Q000494:pharmacology*; D051028:bcl-2-Associated X Protein; D000093842:Matrines
chemical_list: D000470:Alkaloids; D000972:Antineoplastic Agents, Phytogenic; C494826:BAX protein, human; D019253:Proto-Oncogene Proteins c-bcl-2; D011807:Quinolizines; D051028:bcl-2-Associated X Protein; D000093842:Matrines